Escaping the caustic drug war debates through better medications for substance use disorder.| recursiveadaptation.com
Powerful findings in Christian Hendershot's RCT w/ 48 non-treatment seekers and relatively low doses of semaglutide.| recursiveadaptation.com
from CASPR and Institute for Progress (IFP)| www.theseedsofscience.pub
From more than a dozen drinks a day to zero overnight.| recursiveadaptation.com
“I’m now offering GLP-1s to nearly all my substance use disorder patients.”| recursiveadaptation.com
How a Fortune 50 VP controlled his "20 pack-year" and a 5- to 6-drink a night habits.| recursiveadaptation.com
"Everything changed when I was prescribed tirzepatide in 2019."| recursiveadaptation.com
from CASPR and Institute for Progress (IFP)| recursiveadaptation.com
One patient describes how getting on Mounjaro gave her her freedom back.| recursiveadaptation.com
Tirzepatide helped a patient with chronic back pain overcome a cycle of opiate and alcohol overuse.| recursiveadaptation.com
A patient describes how Ozempic and Mounjaro ended her drinking after all else had failed.| recursiveadaptation.com
Why is the disease that causes more deaths than any other still considered a small drug market?| recursiveadaptation.com
Better, more appealing medications for drug use disorders can drive population-level improvements.| recursiveadaptation.com
There’s a strong non-addictive, opioid-replacing painkiller coming soon, but most patients won't be able to get it.| recursiveadaptation.com
Dr.| recursiveadaptation.com
